Replies to post #404073 on NorthWest Biotherapeutics Inc (NWBO)

[hankmanhub]

Becoming a CDMO is not worth our time or our capital. They would be diverting our capital to a low margin start-up selling excess factory capacity to start-ups. I would prefer that my capital be used to get DCVax-L to market ASAP.

The trouble is that any way you look at it, the funds to set up Advent in business as a CDMO are mainly coming from NWBO any way you look at it, even if as you see it as "CDMO payments"? So we reqlyy save nothing to very litlle but it all gets set up inside ADVENT, to the detriment of NWBO shareholders, rather than inside NWBO.